Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKALL 2011 trial for children and young adults with acute lymphoblastic leukemia and lymphoblastic lymphoma
ISRCTN64515327Phase 3Active, not recruiting
- Sponsor
- University of Birmingham
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of dexamethasone, methotrexate and vincristine in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL) and Hodgkin lymphoma (HL) (6 arms), sponsored by University of Birmingham. Started Jan 2012; status: active, not recruiting.
02
Drugs
dexamethasonemethotrexatevincristine
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on ISRCTN64515327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64515327.